T
TACs (trigeminal autonomic cephalgias),
57
taxonomy
International Headache Society classification system,
56–57
nonodontogenic toothache,
55
T-cells (T lymphocytes),
533–534
TCRs (T-cell antigen receptors),
533
TCN (subodontoblastic terminal capillary network),
485f
technology/digital technology
in administrative area,
993
barriers to adoption of,
964
in clinician’s office,
994
computer industry standards,
994–995
digital imaging and communications in medicine (DICOM),
995
e-mail and Internet access,
967
financial software security,
997
health and safety factors for employees,
1004
insurance submissions,
967
open database connectivity,
995
patient education systems,
967
preregistration of patients,
998
radiation protection,
987b
reception area kiosk,
976
referral form/report,
972f
referral tracking software,
997–998
in sterilization area,
993
systematized nomenclature of dentistry (SNODENT),
995
Tell Us About Your Health form,
4f
Tell Us About Your Symptoms form,
3f
telopeptide of the procollagen molecule,
473
temporal artery biopsies,
62
temporal aspects of pain,
64
temporomandibular disorders (TMDs),
57,
433
tensile strength of dentin,
778
tension-type headaches,
57
terminal capillary network (TCN),
484f
terminal periodontal disease,
897–898
termination point for root canal therapy,
147
terminology
attempts to standardize,
36
physical properties of instruments,
230b
test cavity method,
19,
869
tetrodotoxins (TTXs),
673,
692
theoretic pathways of osseous lesion formation,
657–661
theories
central core theory,
701f
on failure to achieve anesthesia,
701
therapeutic modalities,
56
ThermaPrep Plus oven,
270f
thermomechanical pluggers,
381
thermoplastic techniques,
376f,
914
Third Millennium Electronic Commerce Act,
405
Thomas Screw Post Removal Kit,
904–905
Thomas screw post removal technique,
907f
thoracic/cardiac pain,
52
three-canal access cavity preparation,
185f
three-dimensional obturation,
136
throat/neck structures,
61–62
time course of pulpal anesthesia,
703
tissue
damage/injuries to,
478
excisional dentoalveolar wounds,
726–727
failure of prosthetic foundations and,
788f
destruction of adjacent,
812
histopathologic assessment of removed,
745
successful repair of,
882
tissue regeneration,
602,
606
collagen GTR (guided tissue regeneration),
666f
TLP (transmitted light photoplethysmography),
225
T lymphocytes (T-cells)
T-cell antigen receptors (TCRs),
533
TMDs (temporomandibular disorders),
57,
433
Tomes granular layer,
460
tongue swelling, bilateral,
12–13
toothaches
See also pain
from distant organic source,
61–62
as symptom of other disorders,
50
tooth structure
effects of chemicals on,
778
excessive thinning of dental structure,
319f
removal of unsupported,
152
sacrifice of coronal,
151f
structurally compromised teeth,
789–792
structurally sound anterior teeth,
789
torsional load (MacSpadden factor),
310b
totipotent stem cells,
603
transformational elasticity,
306f
transient receptor potential subtype V1 (TRPV1),
673
translucency changes,
780
transmitted light photoplethysmography (TLP),
225
transportation errors,
231
traumatic injuries,
442
adjunctive therapy for,
650
amputation neuroma,
58–59
biologic consequences of
nonvital immature teeth,
630
calcific metamorphosis following,
286
concomitant attachment damage,
625
crown-root fractures,
621
deafferentiation with tissue injuries,
478
nerve sensitization due to,
60
pediatric
pulp diagnosis and treatment planning after,
821
pulpal necrosis secondary to,
613f
radiographic examinations for,
622
revascularization case for pulpal necrosis,
612f
temporary restorations,
651
time between trauma and treatment,
625
unique aspects of dental,
620
treatment methods,
60,
662–667
crown-root fractures,
635
for limiting effects of injuries,
640–641
for posttreatment/persistent disease,
895–898
treatment planning
antianxiety regimens,
97–98
documentation of,
395–397
patient consultation,
395
endodontic therapy versus dental implants,
80
factors influencing case selection,
82–86
medical findings influencing,
72–77,
130–132,
694–695,
728–730
behavioral and psychiatric,
77
bisphosphonate therapy,
75–76
cardiovascular disease,
72–73
end-stage renal disease/dialysis,
76
medically compromised patients,
71
prosthetic implants,
76–77
psychosocial evaluation,
77
patient preparation,
91–98
pediatric, after trauma,
821
periodontal considerations,
77
premedication with antibiotics,
96–97
restorative considerations,
78–79
single-visit versus multiple-visit treatment,
81–82
triatomic oxygen/trioxygen (ozone),
257–258
tricyclic antidepressants,
695t
trigeminal autonomic cephalgias (TACs),
57
trigeminal axon navigation,
455–456
trigeminal nerve,
51f,
54f
maxillary division of,
704f
trigeminal neuralgia,
5–6,
58
trigeminal pain system, action potentials,
674
trimethylene carbonate,
764t
TRPV1 (transient receptor potential subtype V1),
673
true combined lesions,
661f
TTXs (tetrodotoxins),
673,
692
tube-shift technique,
103